127 results
Page 3 of 7
S-8
EX-5.1
ud4nm
30 Jun 21
Registration of securities for employees
4:02pm
S-8
59msz733wep9vjp2
30 Jun 21
Registration of securities for employees
4:02pm
8-K
EX-10.1
7v9qt
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
424B3
00lp8kcqi 7i9ck9spyt
12 Apr 21
Prospectus supplement
1:44pm
S-3
EX-5.1
smi3eim42v7ut1f 03ns
2 Apr 21
Shelf registration
12:00am
S-3
6riehy5a
2 Apr 21
Shelf registration
12:00am
8-K
EX-10.1
5kep8qv5 syjntbo
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.2
2l6j bd3bm1
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
7xzbtsq
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.3
0ij hz6q4x
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-1.1
mmhlg8e35u1tw3c2r5
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
oma4xs9hawerols v2
5 Oct 20
Prospectus supplement with pricing info
4:16pm
S-1MEF
sut27duzv d79
1 Oct 20
Registration of additional securities for an S-1
7:01pm